Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy

Completed · Not applicable

Conditions studied: Diabetes, Gestational, Diabetes, Type 2

In brief

The aim of this study is to compare glycemic control in pregnant women treated with insulin Detemir and pregnant women treated with NPH insulin. These women are diagnosed with gestational diabetes (GDM) in the current pregnancy or have a preexisting diagnosis of type 2 diabetes (T2DM) at the onset of pregnancy. Our hypothesis is that there is no difference between these two treatment modalities in terms of glycemic control in diabetes.

Key facts

Study ID

NCT01837680

Run by

St. Luke's-Roosevelt Hospital Center

People needed

105

Starts

2013-03-01

Expected to finish

2015-03-01

Last updated by the study team

2017-05-30

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• All pregnant women with a viable singleton or multiple gestation at ≤34 weeks with gestational diabetes diagnosed in their current pregnancy requiring medical therapy. "Early diagnosis" GDM patients will also be included; which is defined as a diagnosis made prior to 24 weeks.
• Women with known preexisting type 2 diabetes that are in need of medical therapy.

You may not qualify if…

• Patients <18 years of age
• a diagnosis of GDM outside of the gestational age stated above
• known allergy/prior adverse reaction to insulin NPH or insulin detemir.
• type 1 diabetes

Where it is running

• St. Luke's-Roosevelt Hospital Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.